Physician profile
Sandra Rodriguez
NPI 1043858913
$478.33
in general payments reported to CMS, 2019-2025
10 companies · $230 in 2025
The $230 reported for 2025 was more than what 78% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $77.10 · 2022: $29.95 · 2023: $102 · 2024: $39.43 · 2025: $230.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $371.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $371.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $89.34 | 2021-2025 | |
| Phadia US INC. | $70.88 | 2022-2025 | Immunocap |
| Collegium Pharmaceutical, INC. | $60.65 | 2025 | Jornay Pm |
| Cranial Technologies, INC | $57.68 | 2023-2025 | Doc Band |
| Sequel Med Tech, LLC | $49.84 | 2025 | Twiist |
| Sobi, INC | $45.30 | 2021 | |
| Merck Sharp & Dohme LLC | $40.06 | 2023 | Gardasil 9, Vaxelis, Vaxneuvance |
| Cipher Pharmaceuticals US LLC | $29.95 | 2025 | Spinosad, Natroba |
| Alexion Pharmaceuticals, INC. | $19.31 | 2021 | |
| Seqirus USA INC | $15.32 | 2025 | Flucelvax |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandra Rodriguez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.